A probe into the recent price hikes for some generic drugs appears to be widening. Last week, the U.S. Department of Justice issued subpoenas to two generic drug makers seeking information about their interactions with competitors.

Lannett, a generic drug maker, says a senior sales and marketing executive was served with a grand jury subpoena “relating to a federal investigation of the generic pharmaceutical industry into possible violations” of anti-trust laws.

...